SSA
BBNX

Schonfeld Strategic Advisors’s Beta Bionics BBNX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$597K Buy
+59,624
New +$882K ﹤0.01% 1309
2025
Q4 		– Sell
-183,663
Closed -$3.65M – 2729
2025
Q3 		$3.65M Buy
183,663
+113,488
+162% +$1.99M 0.02% 738
2025
Q2 		$1.02M Sell
70,175
-67,147
-49% -$951K 0.01% 1297
2025
Q1 		$1.68M Buy
+137,322
New +$2.56M 0.01% 1038

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Schonfeld Strategic Advisors's BBNX Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Beta Bionics (BBNX) in Q1 2026: 59,624 shares worth $597K. The stake represents ﹤0.01% of the portfolio and ranks #1309 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in BBNX as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in BBNX in Q1 2025 and has held it in 4 quarters since. The position peaked at $3.65M in Q3 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Schonfeld Strategic Advisors held 59,624 shares of Beta Bionics worth $597K as of Q1 2026.
  • Beta Bionics was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Beta Bionics made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1309 holding.
  • Schonfeld Strategic Advisors first reported a position in Beta Bionics in Q1 2025 and has held it in 4 quarters since.
  • Schonfeld Strategic Advisors's Beta Bionics position peaked at $3.65M in Q3 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.